Prospech Limited
Prospech Limited Fundamental Analysis
Prospech Limited (PRS.AX) shows weak financial fundamentals with a PE ratio of -3.55, profit margin of 0.00%, and ROE of -10.81%. The company generates N/A in annual revenue with weak year-over-year growth of 0.00%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 14.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze PRS.AX's fundamental strength across five key dimensions:
Efficiency Score
WeakPRS.AX struggles to generate sufficient returns from assets.
Valuation Score
ExcellentPRS.AX trades at attractive valuation levels.
Growth Score
ModeratePRS.AX shows steady but slowing expansion.
Financial Health Score
ExcellentPRS.AX maintains a strong and stable balance sheet.
Profitability Score
WeakPRS.AX struggles to sustain strong margins.
Key Financial Metrics
Is PRS.AX Expensive or Cheap?
P/E Ratio
PRS.AX trades at -3.55 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, PRS.AX's PEG of -0.09 indicates potential undervaluation.
Price to Book
The market values Prospech Limited at 0.37 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -4.72 times EBITDA. This is generally considered low.
How Well Does PRS.AX Make Money?
Net Profit Margin
For every $100 in sales, Prospech Limited keeps $0.00 as profit after all expenses.
Operating Margin
Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-10.81 in profit for every $100 of shareholder equity.
ROA
Prospech Limited generates $-9.70 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $-0.01 in free cash annually.
FCF Yield
PRS.AX converts -83.99% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-3.55
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.09
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.37
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.008
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.11
vs 25 benchmark
ROA
Return on assets percentage
-0.10
vs 25 benchmark
ROCE
Return on capital employed
-0.10
vs 25 benchmark
How PRS.AX Stacks Against Its Sector Peers
| Metric | PRS.AX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -3.55 | 24.08 | Better (Cheaper) |
| ROE | -10.81% | 921.00% | Weak |
| Net Margin | 0.00% | -113338.00% (disorted) | Weak |
| Debt/Equity | 0.00 | 0.53 | Strong (Low Leverage) |
| Current Ratio | 1.01 | 5.09 | Neutral |
| ROA | -9.70% | -9816.00% (disorted) | Weak |
PRS.AX outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Prospech Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
0.00%
Industry Style: Cyclical, Commodity, Value
DecliningEPS CAGR
-52.25%
Industry Style: Cyclical, Commodity, Value
DecliningFCF CAGR
-50.92%
Industry Style: Cyclical, Commodity, Value
Declining